Sarah C. Gilbert

University of Oxford - Jenner Institute

SCHOLARLY PAPERS

3

DOWNLOADS
Rank 375

SSRN RANKINGS

Top 375

in Total Papers Downloads

53,036

SSRN CITATIONS

2

CROSSREF CITATIONS

1

Scholarly Papers (3)

1.

Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine

Number of pages: 37 Posted: 01 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Siena - Institute of Global Health, University of the Witwatersrand - South African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit, Federal University of Sao Paulo, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group, University of Oxford - Jenner Institute, University of the Witwatersrand, Soweto Clinical Trials Centre, Soweto Clinical Trials Centre, University of Oxford - Oxford Vaccine Group, Setshaba Research Centre, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of the Witwatersrand - South African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Cape Town - Centre for Lung Infection and Immunology, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Jenner Institute, University of Oxford - Jenner Institute, Wits Reproductive Health & HIV Institute (WRHI), University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Oxford - Oxford Vaccine Group, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University Hospitals Bristol and Weston NHS Foundation Trust, University of London - St George's Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - South African Medical Research Council, Liverpool School of Tropical Medicine - Department of Clinical Sciences, AstraZeneca Pharmaceuticals, University of the Witwatersrand - South African Medical Research Council, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - South African Medical Research Council, University of the Witwatersrand - South African Medical Research Council, North Bristol NHS Trust - Severn Pathology, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, University of Oxford - Oxford Vaccine Group, AstraZeneca Pharmaceuticals, Braziland Hospital São Rafael - Escola Bahiana de Medicina e Saúde Pública, Universidade Federal do Rio Grande do Norte (UFRN), University of Oxford - Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - Perinatal HIV Research Unit, Setshaba Research Centre, University of Oxford - Oxford Vaccine Group, Hospital Quinta D'OR, University of Oxford - Oxford Vaccine Group, NIHR Imperial Clinical Research Facility, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Federal University of Santa Maria (UFSM) - Clinical Research Unit, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Universidade Federal do Rio Grande do Sul, Western General Hospital - Clinical Infection Research Group, Queen Elizabeth University Hospital, University of Cambridge - Department of Medicine, Royal Papworth Hospital - Heart Lung Research Institute, University of Nottingham, AstraZeneca Pharmaceuticals, AstraZeneca Pharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Jenner Institute, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group and affiliation not provided to SSRN
Downloads 44,686 (36)
Citation 3

Abstract:

Loading...

2.

Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)

Number of pages: 40 Posted: 04 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Oxford - Big Data Institute, University of Oxford - Oxford Vaccine Group, University of Cambridge, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group, University of Cambridge, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Jenner Institute, Public Health England - National Infection Service, University of Oxford - Oxford Vaccine Group, Liverpool School of Tropical Medicine - Department of Clinical Sciences, UK Biocentre, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Oxford - Oxford Vaccine Group, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, University of Oxford - Jenner Institute, University of Oxford - Jenner Institute, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of Oxford - Oxford Vaccine Group, University Hospitals Bristol and Weston NHS Foundation Trust, University of Oxford - Jenner Institute, University of Oxford - Jenner Institute, University of London - St George's Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, Public Health England - National Infection Service, University of London - St George's Vaccine Institute, Queen Elizabeth University Hospital, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group, North Bristol NHS Trust - Severn Pathology, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, University of Cambridge, University of Oxford - Oxford Vaccine Group, University of Oxford - Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, NIHR Imperial Clinical Research Facility, University of Oxford - Oxford Vaccine Group, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Western General Hospital - Clinical Infection Research Group, Queen Elizabeth University Hospital, Royal Papworth Hospital - Heart Lung Research Institute, University of Nottingham, AstraZeneca Pharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Jenner Institute, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 8,283 (799)
Citation 5

Abstract:

Loading...

3.

Detection and Quantification of Antibody to SARS-CoV-2 Receptor Binding Domain Provides Enhanced Sensitivity, Specificity and Utility

Number of pages: 30 Posted: 05 Jan 2021
Imperial College London - Section of Infectious Diseases and Immunity, Department of Infectious Disease, Imperial College London, Department of Infectious Disease, Imperial College London, Department of Infectious Disease, Imperial College London, Department of Infection and Immunity, Imperial College Healthcare NHS Trust, Department of Infectious Disease, Imperial College London, Department of Infectious Disease, Imperial College London, Worldwide Influenza Centre, Francis Crick Institute, Worldwide Influenza Centre, Francis Crick Institute, The Wellington Hospital, The Wellington Hospital, The Wellington Hospital, Blood Borne Virus Unit, National Infection Service, Colindale Public Health England, Blood Borne Virus Unit, National Infection Service, Colindale Public Health England, Department of Infectious Disease, Imperial College London, Department of Infectious Disease, Imperial College London, Department of Infectious Disease, Imperial College London, Department of Infectious Disease, Imperial College London, Department of Infectious Disease, Imperial College London, Chromatin Structure and Mobile DNA Laboratory, The Francis Crick Institute, Structural Biology Science Technology Platform, Francis Crick Institute, King's College London, Department of Virology, King’s College Hospital, Imperial College London - Department of Infectious Disease, Department of Infectious Disease, Imperial College London, Department of Infectious Disease, Imperial College London, Imperial College London - Department of Epidemiology and Biostatistics, Jenner Institute, University of Oxford, University of Oxford - Jenner Institute, University of Oxford - Jenner Institute, Department of Infection and Immunity, Imperial College Healthcare NHS Trust, University of Edinburgh - Roslin Institute, Imperial College London - National Heart and Lung Institute, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, affiliation not provided to SSRN, Department of Infectious Disease, Imperial College London and Department of Infectious Disease, Imperial College London
Downloads 67 (395,844)

Abstract:

Loading...